 Narasimhan Rajaram
Concepts (206)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrum Analysis | 13 | 2022 | 70 | 2.830 |
Why?
| | Oxygen | 7 | 2020 | 326 | 1.700 |
Why?
| | Optical Imaging | 7 | 2020 | 25 | 1.520 |
Why?
| | Radiation Tolerance | 3 | 2020 | 85 | 1.400 |
Why?
| | Hemoglobins | 5 | 2022 | 107 | 1.170 |
Why?
| | Tumor Microenvironment | 5 | 2022 | 212 | 1.160 |
Why?
| | Skin Neoplasms | 6 | 2022 | 488 | 1.070 |
Why?
| | Spectrometry, Fluorescence | 5 | 2015 | 45 | 0.970 |
Why?
| | Oxygen Consumption | 4 | 2020 | 183 | 0.930 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 322 | 0.870 |
Why?
| | Radiation-Sensitizing Agents | 2 | 2018 | 53 | 0.770 |
Why?
| | Breast | 2 | 2021 | 85 | 0.760 |
Why?
| | Heat-Shock Response | 1 | 2021 | 28 | 0.750 |
Why?
| | Radiation | 1 | 2020 | 15 | 0.750 |
Why?
| | 4-Chloro-7-nitrobenzofurazan | 4 | 2015 | 6 | 0.740 |
Why?
| | Deoxyglucose | 4 | 2015 | 36 | 0.730 |
Why?
| | Cell Line, Tumor | 14 | 2024 | 1403 | 0.720 |
Why?
| | Head and Neck Neoplasms | 3 | 2019 | 268 | 0.720 |
Why?
| | Hot Temperature | 1 | 2021 | 207 | 0.700 |
Why?
| | Lung Neoplasms | 3 | 2024 | 606 | 0.640 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2019 | 318 | 0.640 |
Why?
| | Biosensing Techniques | 1 | 2018 | 25 | 0.630 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 56 | 0.620 |
Why?
| | Indazoles | 1 | 2018 | 47 | 0.620 |
Why?
| | Animals | 26 | 2024 | 13187 | 0.620 |
Why?
| | Mice | 19 | 2024 | 5739 | 0.610 |
Why?
| | Fluorescent Dyes | 2 | 2014 | 102 | 0.560 |
Why?
| | Spectrum Analysis, Raman | 3 | 2022 | 58 | 0.560 |
Why?
| | Epithelial Cells | 1 | 2018 | 209 | 0.560 |
Why?
| | Nephelometry and Turbidimetry | 3 | 2012 | 4 | 0.530 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 391 | 0.530 |
Why?
| | Carcinoma | 2 | 2022 | 138 | 0.520 |
Why?
| | Photometry | 3 | 2012 | 14 | 0.520 |
Why?
| | Foreign Medical Graduates | 1 | 2015 | 6 | 0.510 |
Why?
| | Health Care Sector | 1 | 2015 | 15 | 0.500 |
Why?
| | Policy | 1 | 2015 | 24 | 0.500 |
Why?
| | Models, Cardiovascular | 2 | 2013 | 21 | 0.490 |
Why?
| | Breast Neoplasms | 5 | 2018 | 1174 | 0.480 |
Why?
| | Blood Vessels | 1 | 2015 | 72 | 0.480 |
Why?
| | Algorithms | 4 | 2018 | 615 | 0.440 |
Why?
| | Glucose | 1 | 2015 | 344 | 0.420 |
Why?
| | Skin | 4 | 2018 | 409 | 0.420 |
Why?
| | Delivery of Health Care | 1 | 2015 | 309 | 0.400 |
Why?
| | Refractometry | 2 | 2012 | 5 | 0.380 |
Why?
| | Lasers, Gas | 1 | 2010 | 7 | 0.380 |
Why?
| | Lasers, Dye | 1 | 2010 | 9 | 0.380 |
Why?
| | Mice, Nude | 5 | 2019 | 252 | 0.370 |
Why?
| | Pigments, Biological | 1 | 2010 | 4 | 0.370 |
Why?
| | Microfluidics | 1 | 2010 | 6 | 0.370 |
Why?
| | Glycolysis | 3 | 2017 | 70 | 0.370 |
Why?
| | Colonic Neoplasms | 2 | 2022 | 161 | 0.360 |
Why?
| | Disease Models, Animal | 4 | 2020 | 1455 | 0.360 |
Why?
| | Carcinoma, Basal Cell | 1 | 2010 | 37 | 0.350 |
Why?
| | Humans | 25 | 2024 | 49974 | 0.330 |
Why?
| | Models, Biological | 2 | 2012 | 727 | 0.330 |
Why?
| | Oximetry | 2 | 2024 | 67 | 0.320 |
Why?
| | Models, Chemical | 1 | 2008 | 66 | 0.320 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2018 | 106 | 0.290 |
Why?
| | Fiber Optic Technology | 2 | 2016 | 16 | 0.250 |
Why?
| | Microscopy, Fluorescence | 2 | 2018 | 162 | 0.250 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2018 | 122 | 0.240 |
Why?
| | Neovascularization, Pathologic | 2 | 2018 | 161 | 0.240 |
Why?
| | Phantoms, Imaging | 5 | 2018 | 121 | 0.240 |
Why?
| | Tumor Cells, Cultured | 3 | 2021 | 465 | 0.230 |
Why?
| | Skin Pigmentation | 1 | 2024 | 11 | 0.230 |
Why?
| | Fluorouracil | 2 | 2022 | 54 | 0.230 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 211 | 0.220 |
Why?
| | Scattering, Radiation | 4 | 2015 | 31 | 0.200 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 154 | 0.200 |
Why?
| | CTLA-4 Antigen | 1 | 2021 | 25 | 0.200 |
Why?
| | Neoplasms, Second Primary | 1 | 2022 | 78 | 0.200 |
Why?
| | Female | 15 | 2021 | 26472 | 0.190 |
Why?
| | Poultry | 1 | 2021 | 25 | 0.190 |
Why?
| | Animal Feed | 1 | 2021 | 58 | 0.190 |
Why?
| | Reproducibility of Results | 5 | 2012 | 1193 | 0.190 |
Why?
| | Meat | 1 | 2021 | 55 | 0.190 |
Why?
| | Neoplasm Metastasis | 3 | 2022 | 231 | 0.190 |
Why?
| | Sensitivity and Specificity | 4 | 2012 | 861 | 0.180 |
Why?
| | Chickens | 1 | 2021 | 107 | 0.180 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2020 | 184 | 0.180 |
Why?
| | Spectrophotometry | 1 | 2020 | 33 | 0.180 |
Why?
| | Equipment Design | 5 | 2014 | 284 | 0.180 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2020 | 37 | 0.180 |
Why?
| | Radiotherapy | 1 | 2020 | 128 | 0.170 |
Why?
| | Mice, Inbred BALB C | 4 | 2022 | 304 | 0.170 |
Why?
| | Mitochondria, Heart | 1 | 2019 | 35 | 0.160 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2018 | 5 | 0.160 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2018 | 61 | 0.160 |
Why?
| | Nitroimidazoles | 1 | 2018 | 15 | 0.160 |
Why?
| | NAD | 1 | 2018 | 43 | 0.160 |
Why?
| | Terahertz Imaging | 1 | 2018 | 1 | 0.160 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 35 | 0.150 |
Why?
| | Cancer Vaccines | 1 | 2018 | 78 | 0.150 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 114 | 0.150 |
Why?
| | Organometallic Compounds | 1 | 2018 | 44 | 0.150 |
Why?
| | Immunohistochemistry | 1 | 2020 | 973 | 0.150 |
Why?
| | Antineoplastic Agents | 2 | 2024 | 1171 | 0.140 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 236 | 0.140 |
Why?
| | Cytoskeleton | 1 | 2016 | 39 | 0.140 |
Why?
| | Equipment Failure Analysis | 3 | 2012 | 46 | 0.140 |
Why?
| | Heart Valves | 1 | 2016 | 24 | 0.140 |
Why?
| | Myocardium | 1 | 2019 | 436 | 0.130 |
Why?
| | Muscle Contraction | 1 | 2016 | 105 | 0.130 |
Why?
| | Mouth | 1 | 2016 | 33 | 0.130 |
Why?
| | Cell Nucleus | 1 | 2016 | 183 | 0.130 |
Why?
| | Melanoma | 2 | 2022 | 285 | 0.130 |
Why?
| | RNA, Messenger | 1 | 2019 | 1105 | 0.130 |
Why?
| | Models, Statistical | 2 | 2018 | 224 | 0.130 |
Why?
| | Blood Glucose | 2 | 2015 | 439 | 0.130 |
Why?
| | India | 1 | 2015 | 51 | 0.130 |
Why?
| | China | 1 | 2015 | 87 | 0.120 |
Why?
| | Transducers | 2 | 2012 | 20 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2018 | 614 | 0.120 |
Why?
| | Energy Metabolism | 1 | 2016 | 282 | 0.120 |
Why?
| | Sulfur Dioxide | 1 | 2013 | 3 | 0.120 |
Why?
| | Blood Volume | 2 | 2011 | 68 | 0.110 |
Why?
| | Health Education | 1 | 2015 | 156 | 0.110 |
Why?
| | Regional Blood Flow | 1 | 2013 | 108 | 0.110 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2013 | 50 | 0.110 |
Why?
| | Diagnostic Imaging | 2 | 2011 | 176 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 1159 | 0.100 |
Why?
| | Kinetics | 1 | 2013 | 623 | 0.100 |
Why?
| | Molecular Imaging | 1 | 2012 | 53 | 0.100 |
Why?
| | Glycerol | 1 | 2011 | 15 | 0.100 |
Why?
| | Sclera | 1 | 2011 | 5 | 0.100 |
Why?
| | Computer Simulation | 2 | 2012 | 280 | 0.100 |
Why?
| | Choroid | 1 | 2011 | 22 | 0.100 |
Why?
| | Skin Temperature | 1 | 2011 | 15 | 0.100 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 408 | 0.090 |
Why?
| | Body Temperature | 1 | 2011 | 69 | 0.090 |
Why?
| | Adenocarcinoma | 1 | 2014 | 396 | 0.090 |
Why?
| | Neoplasms | 1 | 2020 | 1235 | 0.090 |
Why?
| | Microvessels | 1 | 2010 | 29 | 0.090 |
Why?
| | Epithelium | 1 | 2010 | 65 | 0.090 |
Why?
| | Artifacts | 1 | 2011 | 53 | 0.090 |
Why?
| | Computer-Aided Design | 1 | 2010 | 21 | 0.090 |
Why?
| | Lung | 1 | 2013 | 486 | 0.090 |
Why?
| | Immunotherapy | 2 | 2022 | 238 | 0.090 |
Why?
| | Pilot Projects | 1 | 2010 | 699 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 903 | 0.080 |
Why?
| | Time Factors | 1 | 2013 | 2903 | 0.070 |
Why?
| | Brain | 1 | 2013 | 1328 | 0.060 |
Why?
| | Buthionine Sulfoximine | 1 | 2024 | 14 | 0.060 |
Why?
| | Carboplatin | 1 | 2024 | 53 | 0.060 |
Why?
| | Cisplatin | 1 | 2024 | 278 | 0.050 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 308 | 0.050 |
Why?
| | Light | 2 | 2012 | 71 | 0.050 |
Why?
| | Healthcare Disparities | 1 | 2024 | 257 | 0.050 |
Why?
| | Mice, Inbred A | 1 | 2020 | 15 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 83 | 0.040 |
Why?
| | Phenotype | 1 | 2022 | 729 | 0.040 |
Why?
| | Macrophages | 1 | 2022 | 363 | 0.040 |
Why?
| | Mice, Obese | 1 | 2019 | 21 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 90 | 0.040 |
Why?
| | Down-Regulation | 1 | 2019 | 348 | 0.040 |
Why?
| | Gene Deletion | 1 | 2018 | 266 | 0.040 |
Why?
| | Disease Progression | 1 | 2020 | 825 | 0.040 |
Why?
| | Tooth Apex | 1 | 2016 | 1 | 0.040 |
Why?
| | Optical Fibers | 1 | 2016 | 7 | 0.040 |
Why?
| | Body Weight | 1 | 2019 | 513 | 0.040 |
Why?
| | Shear Strength | 1 | 2016 | 9 | 0.040 |
Why?
| | Cell Size | 1 | 2016 | 45 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2024 | 2772 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2016 | 88 | 0.030 |
Why?
| | Keratinocytes | 1 | 2016 | 90 | 0.030 |
Why?
| | Infant | 1 | 2024 | 3567 | 0.030 |
Why?
| | Child, Preschool | 1 | 2024 | 3871 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 85 | 0.030 |
Why?
| | Aging | 1 | 2019 | 687 | 0.030 |
Why?
| | Halogenation | 1 | 2013 | 6 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 2013 | 35 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2013 | 68 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 70 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 1816 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 2013 | 101 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2013 | 74 | 0.030 |
Why?
| | Aerobiosis | 1 | 2013 | 14 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2013 | 53 | 0.030 |
Why?
| | Mice, SCID | 1 | 2013 | 175 | 0.030 |
Why?
| | Rats, Nude | 1 | 2012 | 2 | 0.030 |
Why?
| | Young Adult | 2 | 2014 | 3958 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2016 | 1573 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 113 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2012 | 82 | 0.030 |
Why?
| | Diffusion | 1 | 2011 | 15 | 0.030 |
Why?
| | Monte Carlo Method | 1 | 2012 | 84 | 0.030 |
Why?
| | Optical Phenomena | 1 | 2011 | 11 | 0.020 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2011 | 11 | 0.020 |
Why?
| | Melanins | 1 | 2011 | 27 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2011 | 62 | 0.020 |
Why?
| | Eye | 1 | 2011 | 31 | 0.020 |
Why?
| | Male | 3 | 2019 | 25241 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 192 | 0.020 |
Why?
| | Pressure | 1 | 2011 | 105 | 0.020 |
Why?
| | Rabbits | 1 | 2011 | 370 | 0.020 |
Why?
| | Models, Animal | 1 | 2011 | 233 | 0.020 |
Why?
| | Obesity | 1 | 2019 | 1113 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 395 | 0.020 |
Why?
| | Swine | 1 | 2011 | 393 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2018 | 5141 | 0.020 |
Why?
| | Adult | 2 | 2014 | 13236 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2014 | 3129 | 0.020 |
Why?
| | Rats | 1 | 2012 | 3305 | 0.020 |
Why?
| | Aged | 1 | 2014 | 9310 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 6356 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 12069 | 0.010 |
Why?
|
|
Rajaram's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|